| 000 | 01750 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518042123.0 | ||
| 264 | 0 | _c20210204 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1537-6613 | ||
| 024 | 7 |
_a10.1093/infdis/jiz281 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGandhi, Rajesh T | |
| 245 | 0 | 0 |
_aLong-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS). _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _c04 2020 |
||
| 300 |
_a1407-1415 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV-1 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 700 | 1 | _aTashima, Karen T | |
| 700 | 1 | _aSmeaton, Laura M | |
| 700 | 1 | _aVu, Vincent | |
| 700 | 1 | _aRitz, Justin | |
| 700 | 1 | _aAndrade, Adriana | |
| 700 | 1 | _aEron, Joseph J | |
| 700 | 1 | _aHogg, Evelyn | |
| 700 | 1 | _aFichtenbaum, Carl J | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 221 _gno. 9 _gp. 1407-1415 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/jiz281 _zAvailable from publisher's website |
| 999 |
_c29736553 _d29736553 |
||